Skip to main content

Advertisement

SpringerLink
Log in

New Paradigm in the Management of REM Sleep Behavior Disorder

  • SLEEP AND NEUROLOGICAL CONDITIONS (A AVIDAN, SECTION EDITOR)
  • Published:
Current Sleep Medicine Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Rapid eye movement (REM) behavior disorder (RBD) is a complex parasomnia, with growing evidence showing that it represents a prodromal marker for the development of alpha-synuclein neurodegenerative disease. The treatment of RBD previously lacked strong evidence until now. In this paper, we aim to review the current and newly emerging options for the treatment of RBD.

Recent Findings

The best current evidence in the pharmacologic therapies for RBD is based on small clinical trials and case studies. Clonazepam and melatonin remain the initial standard of treatment and are used as an off-label for RBD. Additional pharmacologic agents have shown potential promise for controlling RBD symptoms, but more research is needed. Currently, large international initiatives such as the IRBDSG, the NAPS consortium, and the PPMI 2.0 are actually recruiting RBD patients into registries to better understand the pathophysiology of RBD, potential biomarkers that indicate phenoconversion to alpha-synuclein states, and to promote further research in neuroprotective trials for disease prevention.

Summary

The current literature highlights the exciting opportunities to conduct appropriately designed, large-scale, randomized, controlled trials to advance the management of RBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Porter V, Avidan A. Clinical overview of REM sleep behavior disorder. Semin Neurol. 2017;37(04):461–70.

    Article  PubMed  Google Scholar 

  2. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293–308.

    Article  CAS  PubMed  Google Scholar 

  3. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123(2):331–9.

    Article  PubMed  Google Scholar 

  4. Thorpy MJ. ICSD - International classification of sleep disorders, revised: diagnostic and coding manual. Chicago, Illinois: American Academy of Sleep Medicine; 2001.

  5. Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013;14(8):795–806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cesari M, Heidbreder A, St. Louis EK, Sixel-Döring F, Bliwise DL, Baldelli L, et al. Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group. Sleep. 2022;45(3):257.

    Article  Google Scholar 

  7. •• Miglis MG, Adler CH, Antelmi E, Arnaldi D, Baldelli L, Boeve BF, et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. The Lancet Neurology. 2021;20(8):671–84. This study highlights the available biomarkers for the evaluation of the risk of phenoconversion.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Iranzo A, Fernández-Arcos A, Tolosa E, Serradell M, Molinuevo JL, Valldeoriola F, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. Toft M editor PLoS ONE. 2014;9(2):e89741.

    Article  Google Scholar 

  9. •• Postuma RB, Gagnon JF, Bertrand JA, Génier Marchand D, Montplaisir JY. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology. 2015;84(11):1104. A key study in identifying factors of phenoconversion of RBD into Parkinson’s disease.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sasai-Sakuma T, Takeuchi N, Asai Y, Inoue Y, Inoue Y. Prevalence and clinical characteristics of REM sleep behavior disorder in Japanese elderly people. Sleep. 2020;43(8):zsaa024.

    Article  PubMed  Google Scholar 

  11. Pujol M, Pujol J, Alonso T, Fuentes A, Pallerola M, Freixenet J, et al. Idiopathic REM sleep behavior disorder in the elderly Spanish community: a primary care center study with a two-stage design using video-polysomnography. Sleep Med. 2017;40:116–21.

    Article  PubMed  Google Scholar 

  12. Haba-Rubio J, Frauscher B, Marques-Vidal P, Toriel J, Tobback N, Andries D, et al. Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population. Sleep. 2018;41(2):zsx197.

    Article  PubMed  Google Scholar 

  13. •• Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744–59. An important study that identifies predictors of RBD phenoconversion.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Berry RB, Quan SF, Abreu AR, Bibbs ML, DelRosso L, Harding SM, et al. AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 2.6. Vol. 1. Darien, IL: American Academy of Sleep Medicine; 2020. p. 98.

  15. Boesch SM, Frauscher B, Brandauer E, Wenning GK, Högl B, Poewe W. Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2. Mov Disord. 2006;21(10):1751–4.

    Article  PubMed  Google Scholar 

  16. Zambelis T. REM sleep behaviour disorder associated with a neurinoma of the left pontocerebellar angle. J Neurol Neurosurg Psychiatry. 2002;72(6):821–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tachibana N, Kimura K, Kitajima K, Shinde A, Kimura J, Shibasaki H. REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. J Neurol Neurosurg Psychiatry. 1997;63(5):678–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tison F, Wenning GK, Quinn NP, Smith SJ. REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58(3):379–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Gómez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13(6):805–8.

    Article  PubMed  Google Scholar 

  20. Xi Z, Luning W. REM sleep behavior disorder in a patient with pontine stroke. Sleep Med. 2009;10(1):143–6.

    Article  PubMed  Google Scholar 

  21. Roguski A, Rayment D, Whone AL, Jones MW, Rolinski M. A neurologist’s guide to REM sleep behavior disorder. Front Neurol. 2020;8(11):610.

    Article  Google Scholar 

  22. Sforza E, Krieger J, Petiau C. REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev. 1997;1(1):57–69.

    Article  CAS  PubMed  Google Scholar 

  23. Nightingale S, Orgill JC, Ebrahim IO, de Lacy SF, Agrawal S, Williams AJ. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med. 2005;6(3):253–8.

    Article  CAS  PubMed  Google Scholar 

  24. Nevsimalova S, Prihodova I, Kemlink D, Lin L, Mignot E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med. 2007;8(7–8):784–6.

    Article  PubMed  Google Scholar 

  25. Dauvilliers Y, Rompré S, Gagnon JF, Vendette M, Petit D, Montplaisir J. REM Sleep Characteristics in narcolepsy and REM sleep behavior disorder. Sleep. 2007;30(7):844.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Iranzo A, Santamaría J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep. 2005;28(2):203–6.

    Article  PubMed  Google Scholar 

  27. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25(2):120–38.

    Article  PubMed  Google Scholar 

  28. Schenck CH, Mahowald MW. Polysomnographie, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. CCJM. 1990;57(1 suppl 1):S9–23.

    Google Scholar 

  29. Goyal A, Pawar KS, Khurana A, Kumar S. A case of pseudo-RBD with OSA. Sleep Vigilance. 2018;2(1):87–9.

    Article  Google Scholar 

  30. Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med. 1999;107(4):390–2.

    Article  CAS  PubMed  Google Scholar 

  31. Teman PT, Tippmann-Peikert M, Silber MH, Slocumb NL, Auger RR. Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med. 2009;10(1):60–5.

    Article  PubMed  Google Scholar 

  32. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep. 2004;27(2):317–21.

    Article  PubMed  Google Scholar 

  33. •• Oertel W, Mayer G, Salminen AV, Schenck CH. The Foundation of the International RBD Study Group (IRBDSG). In: Schenck CH, Högl B, Videnovic A, editors. Rapid-eye-movement sleep behavior disorder. Cham: Springer International Publishing; 2019. Available from: https://doi.org/10.1007/978-3-319-90152-7_3. This study provides important advancement in the creation of RBD groups.

  34. • Yo-El Ju. North American Prodromal Synucleinopathy Consortium (NAPS). ClinicalTrials.gov. Identifier: NCT03623672. Available from: https://clinicaltrials.gov/ct2/show/NCT03623672. Accessed 3 Feb 2023. This study provides important advancement in the creation of RBD management groups.

  35. • MD KM. PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort (PPMI). ClinicalTrials.gov. Report No.: NCT04477785. Available from: https://clinicaltrials.gov/ct2/show/NCT04477785. Accessed 6 July 2022. This study highlights important markers in relation between RBD and neurodegenerative diseases.

  36. •• Zhang H, Iranzo A, Högl B, Arnulf I, Ferini-Strambi L, Manni R, et al. Risk factors for phenoconversion in rapid eye movement sleep behavior disorder. Ann Neurol. 2022;91(3):404–16. This is a major study identified important risk factors for RBD phenoconversion.

    Article  CAS  PubMed  Google Scholar 

  37. •• Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77(5):830–9. This is a major study identified important risk factors for RBD phenoconversion.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Roos DS, Klein M, Deeg DJH, Doty RL, Berendse HW. Prevalence of prodromal symptoms of Parkinson’s disease in the late middle-aged population. J Parkinsons Dis. 2022;12(3):967–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, et al. Imaging prodromal Parkinson disease. Neurology. 2014;83(19):1739–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Iakovakis D, Chaudhuri KR, Klingelhoefer L, Bostantjopoulou S, Katsarou Z, Trivedi D, et al. Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing via deep learning. Sci Rep. 2020;10(1):12623.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Arora S, Baig F, Lo C, Barber TR, Lawton MA, Zhan A, et al. Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD. Neurology. 2018;91(16):e1528–38.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Noyce AJ, R’Bibo L, Peress L, Bestwick JP, Adams-Carr KL, Mencacci NE, et al. PREDICT-PD: an online approach to prospectively identify risk indicators of Parkinson’s disease. Mov Disord. 2017;32(2):219–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Heinzel (2019) Prodromal PD Calculator. In: International Parkinson and Movement Disorder Society. https://www.movementdisorders.org/MDS/Members-Only/Prodromal-PDCalculator.htm. Accessed 5 Sept 2022.

  44. American Academy of Sleep Medicine. International classification of sleep disorders. Third edition. Darien IL: American Academy of Sleep Medicine; 2014.

  45. Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration — an update. Nat Rev Neurol. 2018;14(1):40–55.

    Article  PubMed  Google Scholar 

  46. McCarter SJ, St. Louis EK, Duwell EJ, Timm PC, Sandness DJ, Boeve BF, et al. Diagnostic thresholds for quantitative REM sleep phasic burst duration, phasic and tonic muscle activity, and REM atonia index in REM sleep behavior disorder with and without comorbid obstructive sleep apnea. Sleep. 2014;37(10):1649–62.

    Article  PubMed  PubMed Central  Google Scholar 

  47. McCarter SJ, Sandness DJ, McCarter AR, Feemster JC, Teigen LN, Timm PC, et al. REM sleep muscle activity in idiopathic REM sleep behavior disorder predicts phenoconversion. Neurology. 2019;93(12):e1171–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Frauscher B, Iranzo A, Gaig C, Gschliesser V, Guaita M, Raffelseder V, et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. 2012;35(6):835–47.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Feemster JC, Jung Y, Timm PC, Westerland SM, Gossard TR, Teigen LN, et al. Normative and isolated rapid eye movement sleep without atonia in adults without REM sleep behavior disorder. Sleep. 2019;42(10):zsz124.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Iranzo A, Ratti PL, Casanova-Molla J, Serradell M, Vilaseca I, Santamaria J. Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder. Sleep. 2009;32(9):1149–53.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Gossard TR, Teigen LN, Yoo S, Timm PC, Jagielski J, Bibi N, et al. Patient values and preferences regarding prognostic counseling in isolated REM sleep behavior disorder. Sleep. 2022;46(1):zsac244. https://doi.org/10.1093/sleep/zsac244.

  52. • Aurora RN, Zak RS, Maganti RK, Auerbach SH, Casey KR, Chowdhuri S, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6(1):85–95. This article highlights the current guidelines for the management of RBD.

  53. •• Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100(3):333–7. This article provides evidence for the main treatments of RBD.

    Article  CAS  PubMed  Google Scholar 

  54. Shin C, Park H, Lee WW, Kim HJ, Kim HJ, Jeon B. Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: a randomized placebo-controlled trial. J Neurol Sci. 2019;401:81–6.

    Article  CAS  PubMed  Google Scholar 

  55. Raggi A, Mogavero MP, DelRosso LM, Ferri R. Clonazepam for the management of sleep disorders. Neurol Sci. 2022;44(1):115–28. https://doi.org/10.1007/s10072-022-06397-x.

    Article  PubMed  Google Scholar 

  56. McGrane IR, Leung JG, St. Louis EK, Boeve BF. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Medicine. 2015;16(1):19–26.

    Article  PubMed  Google Scholar 

  57. Jun J, Kim R, Byun J, Kim T, Lim J, Sunwoo J, et al. Prolonged–release melatonin in patients with idiopathic REM sleep behavior disorder. Ann Clin Transl Neurol. 2019;6(4):716–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Gilat M, Coeytaux Jackson A, Marshall NS, Hammond D, Mullins AE, Hall JM, et al. Melatonin for rapid eye movement sleep behavior disorder in Parkinson’s disease: a randomised controlled trial. Mov Disord. 2020;35(2):344–9.

    Article  CAS  PubMed  Google Scholar 

  59. Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi PH, Plazzi G, et al. REM sleep behaviour disorder. Nat Rev Dis Primers. 2018;4(1):1–16.

    Article  Google Scholar 

  60. Yan J, Liu A, Huang J, Wu J, Shen R, Ma H, et al. Pharmacological interventions for REM sleep behavior disorder in Parkinson’s disease: a systematic review. Front Aging Neurosci. 2021;13:709878. https://doi.org/10.3389/fnagi.2021.709878.

  61. Matar E, McCarter SJ, St Louis EK, Lewis SJG. Current concepts and controversies in the management of REM sleep behavior disorder. Neurotherapeutics. 2021;18(1):107–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. McCarter SJ, Boswell CL, St. Louis EK, Dueffert LG, Slocumb N, Boeve BF, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Medicine. 2013;14(3):237–42.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Boeve B. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281–4.

    Article  PubMed  Google Scholar 

  64. Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology. 1998;51(2):363–70.

    Article  CAS  PubMed  Google Scholar 

  65. Gilat M, Marshall NS, Testelmans D, Buyse B, Lewis SJG. A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials. J Neurol. 2022;269(1):125–48.

    Article  PubMed  Google Scholar 

  66. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder Comparison with Parkinson’s disease and controls. Brain. 2000;123(Pt 6):1155–60.

    Article  PubMed  Google Scholar 

  67. Iyer V, Vo Q, Mell A, Chinniah S, Zenerovitz A, Venkiteswaran K, et al. Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats. NPJ Parkinsons Dis. 2019;5:27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Garcia-Borreguero D, Caminero AB, de la Llave Y, Larrosa O, Barrio S, Granizo JJ, et al. Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson’s disease: effects of treatment with levodopa and progression of illness. Mov Disord. 2002;17(5):934–41.

    Article  PubMed  Google Scholar 

  69. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord. 1996;11(2):214–6.

    Article  CAS  PubMed  Google Scholar 

  70. Özekmekçi S, Apaydin H, Kiliç E. Clinical features of 35 patients with Parkinson’s disease displaying REM behavior disorder. Clin Neurol Neurosurg. 2005;107(4):306–9.

    Article  PubMed  Google Scholar 

  71. Meloni M, Bortolato M, Cannas A, Laccu I, Figorilli M, Congiu P, et al. Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study. J Neurol. 2020;267(10):2926–31.

    Article  CAS  PubMed  Google Scholar 

  72. Kim YE, Jeon BS, Yang HJ, Ehm G, Yun JY, Kim HJ, et al. REM sleep behavior disorder: association with motor complications and impulse control disorders in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(10):1081–4.

    Article  PubMed  Google Scholar 

  73. Cao R, Ma R, Wang K, Hu P. Association between dopaminergic medications and the evolution of REM sleep behavior disorder in Parkinson’s disease. Front Neurol. 2022;13: 880583.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Sasai T, Matsuura M, Inoue Y. Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord. 2013;19(2):153–7.

    Article  PubMed  Google Scholar 

  75. Fantini ML, Gagnon JF, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology. 2003;61(10):1418–20.

    Article  CAS  PubMed  Google Scholar 

  76. Schmidt MH, Koshal VB, Schmidt HS. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med. 2006;7(5):418–23.

    Article  PubMed  Google Scholar 

  77. Kumru H, Iranzo A, Carrasco E, Valldeoriola F, Marti MJ, Santamaria J, et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep. 2008;31(10):1418–21.

    PubMed  PubMed Central  Google Scholar 

  78. Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep. 1997;20(9):757–88.

    Article  CAS  PubMed  Google Scholar 

  79. Di Giacopo R, Fasano A, Quaranta D, Marca GD, Bove F, Bentivoglio AR. Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson’s disease: rivastigmine for rem behavior disorder. Mov Disord. 2012;27(4):559–61.

    Article  PubMed  Google Scholar 

  80. Brunetti V, Losurdo A, Testani E, Lapenta L, Mariotti P, Marra C, et al. Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. CAR. 2014;11(3):267–73.

    Article  CAS  Google Scholar 

  81. Ringman JM, Simmons JH. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology. 2000;55(6):870–1.

    Article  CAS  PubMed  Google Scholar 

  82. Anderson KN, Shneerson JM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med. 2009;5(3):235–9.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Bonakis A, Howard RS, Williams A. Narcolepsy presenting as REM sleep behaviour disorder. Clin Neurol Neurosurg. 2008;110(5):518–20.

    Article  PubMed  Google Scholar 

  84. Abenza Abildúa MJ, Miralles Martinez A, Arpa Gutiérrez FJ, Lores Gutiérrez V, Algarra Lucas C, Jimeno Montero C, et al. Conditions associated with REM sleep behaviour disorder: description of a hospital series. Neurologia (Engl Ed). 2019;34(3):159–64.

    Article  PubMed  Google Scholar 

  85. Gowda CR, Lundt LP. Mechanism of action of narcolepsy medications. CNS Spectr. 2014;19(S1):25–34.

    Article  PubMed  Google Scholar 

  86. Dominguez A, Soca Gallego L, Parmar M. Sodium Oxybate. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: http://www.ncbi.nlm.nih.gov/books/NBK562283/.

  87. Gompf HS, Aston-Jones G. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res. 2008;11(1224):43–52.

    Article  Google Scholar 

  88. Moghadam KK, Pizza F, Primavera A, Ferri R, Plazzi G. Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients. Sleep Med. 2017;1(32):16–21.

    Article  Google Scholar 

  89. Shneerson JM. Successful treatment of REM sleep behavior disorder with sodium oxybate. Clin Neuropharmacol. 2009;32(3):158–9.

    Article  CAS  PubMed  Google Scholar 

  90. Antelmi E, Plazzi G. Rapid eye movement sleep behavior disorder and sodium oxybate: efficacy and viewpoint. Sleep. 2022;43(11):zsaa149.

    Article  Google Scholar 

  91. Liebenthal J, Valerio J, Ruoff C, Mahowald M. A case of rapid eye movement sleep behavior disorder in parkinson disease treated with sodium oxybate. JAMA Neurol. 2016;73(1):126.

    Article  PubMed  Google Scholar 

  92. During E. Treatment of REM sleep behavior disorder (RBD) with sodium oxybate.. ClinicalTrials.gov. Identifier: NCT04006925. Available from: https://clinicaltrials.gov/ct2/show/NCT04006925. Accessed 3 Feb 2023.

  93. Nomura T, Kawase S, Watanabe Y, Nakashima K. Use of ramelteon for the treatment of secondary REM sleep behavior disorder. Intern Med. 2013;52(18):2123–6.

    Article  PubMed  Google Scholar 

  94. Esaki Y, Kitajima T, Koike S, Fujishiro H, Iwata Y, Tsuchiya A, et al. An open-labeled trial of ramelteon in idiopathic rapid eye movement sleep behavior disorder. J Clin Sleep Med. 2016;12(5):689–93.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Kashihara K, Nomura T, Maeda T, Tsuboi Y, Mishima T, Takigawa H, et al. Beneficial effects of ramelteon on rapid eye movement sleep behavior disorder associated with Parkinson’s disease - results of a multicenter open trial. Intern Med. 2016;55(3):231–6.

    Article  CAS  PubMed  Google Scholar 

  96. St. Louis EK, McCarter SJ, Boeve BF. Ramelteon for idiopathic REM sleep behavior disorder: implications for pathophysiology and future treatment trials. J Clin Sleep Med. 2016;12(5):643–5.

    Article  PubMed Central  Google Scholar 

  97. Plastino M, Gorgone G, Fava A, Ettore M, Iannacchero R, Scarfone R, et al. Effects of safinamide on REM sleep behavior disorder in Parkinson disease: a randomized, longitudinal, cross-over pilot study. J Clin Neurosci. 2021;91:306–12.

    Article  CAS  PubMed  Google Scholar 

  98. Meloni M, Figorilli M, Carta M, Tamburrino L, Cannas A, Sanna F, et al. Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson’s disease. Sleep Breath. 2022;26(3):1023–31.

    Article  PubMed  Google Scholar 

  99. Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A. Review: Deep brain stimulation in Parkinson’s disease. Ther Adv Neurol Disord. 2009;2(6):379–91.

    Article  Google Scholar 

  100. Dulski J, Wąż P, Konkel A, Grabowski K, Libionka W, Schinwelski M, et al. The impact of subthalamic deep brain stimulation on restless legs syndrome in Parkinson’s disease. Neuromodulation: Journal of the International Neuromodulation Society. 2022;25(6):904–10. https://doi.org/10.1111/ner.13462.

  101. Amara AW, Watts RL, Walker HC. The effects of deep brain stimulation on sleep in Parkinson’s disease. Ther Adv Neurol Disord. 2011;4(1):15–24.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Cavalloni F, Debove I, Lachenmayer ML, Krack P, Pollo C, Schuepbach WMM, et al. A case series and systematic review of rapid eye movement sleep behavior disorder outcome after deep brain stimulation in Parkinson’s disease. Sleep Med. 2021;77:170–6.

    Article  PubMed  Google Scholar 

  103. Park S, Kim R, Shin JH, Kim HJ, Paek SH, Jeon B. The probable REM sleep behavior disorder negatively affects health-related quality of life in Parkinson’s disease with bilateral subthalamic nucleus stimulation. Parkinsonism Relat Disord. 2020;81:136–9.

    Article  PubMed  Google Scholar 

  104. Arnulf I. REM sleep behavior disorder: motor manifestations and pathophysiology. Mov Disord. 2012;27(6):677–89.

    Article  PubMed  Google Scholar 

  105. McCarter SJ, Howell MJ. Importance of rapid eye movement sleep behavior disorder to the primary care physician. Mayo Clin Proc. 2016;91(10):1460–6.

    Article  PubMed  Google Scholar 

  106. Howell MJ, Arneson PA, Schenck CH. A novel therapy for REM sleep behavior disorder (RBD). J Clin Sleep Med. 2011;7(6):639-644A.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Yo-El SJ, Bradley B. Neuroprotective treatment trial planning in REM sleep behavior disorder. Mayo Clinic. [cited 2022 Jul 11]. Available from: https://mayoclinic.pure.elsevier.com/en/projects/neuroprotective-treatment-trial-planning-in-rem-sleep-behavior-di-2.

  108. Postuma RB. Neuroprotective trials in REM sleep behavior disorder: the way forward becomes clearer. Neurology. 2022;99(7 Suppl 1):19–25.

    Article  PubMed  Google Scholar 

  109. •• Howell MJ, Avidan AY, Foldvary-Schaefer N et al. Management of REM sleep behavior disorder: an American academy of sleep medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2022. The updated RBD management guidelines, which are accepted for publication.

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary, Critical Care, and Sleep Medicine, College of Medicine, The University of Arizona, Phoenix, AZ, USA

    Anas Rihawi & Joyce K. Lee-Iannotti

  2. Department of Pulmonary, Allergy, Critical Care, and Sleep Medicine, College of Medicine Tucson, The University of Arizona, 1625 N Campbell Ave, Tucson, AZ, 85719, USA

    Saif Mashaqi

  3. Department of Neurology, Division of Movement Disorders, New York, NY, USA

    Emmanuel H. During

  4. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 100029, USA

    Emmanuel H. During

Authors
  1. Anas Rihawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saif Mashaqi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joyce K. Lee-Iannotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emmanuel H. During
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anas Rihawi.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Sleep and Neurological Conditions

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rihawi, A., Mashaqi, S., Lee-Iannotti, J.K. et al. New Paradigm in the Management of REM Sleep Behavior Disorder. Curr Sleep Medicine Rep 9, 23–34 (2023). https://doi.org/10.1007/s40675-023-00248-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40675-023-00248-7

Keywords

Search

Navigation